-
1
-
-
0027752805
-
The L-arginine-nitric oxide pathway
-
Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
-
(1993)
N Engl J Med
, vol.329
, pp. 2002-2012
-
-
Moncada, S.1
Higgs, A.2
-
2
-
-
0026548912
-
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
-
Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575.
-
(1992)
Lancet
, vol.339
, pp. 572-575
-
-
Vallance, P.1
Leone, A.2
Calver, A.3
Collier, J.4
Moncada, S.5
-
3
-
-
22844443807
-
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension
-
Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, et al. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005; 46:518-523.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 518-523
-
-
Perticone, F.1
Sciacqua, A.2
Maio, R.3
Perticone, M.4
Maas, R.5
Boger, R.H.6
-
4
-
-
0037143637
-
Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
-
Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002; 106:987-992.
-
(2002)
Circulation
, vol.106
, pp. 987-992
-
-
Lin, K.Y.1
Ito, A.2
Asagami, T.3
Tsao, P.S.4
Adimoolam, S.5
Kimoto, M.6
-
5
-
-
0242322346
-
Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: its role in hypercholesterolemia
-
Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98:1842-1847.
-
(1998)
Circulation
, vol.98
, pp. 1842-1847
-
-
Böger, R.H.1
Bode-Böger, S.M.2
Szuba, A.3
Tsao, P.S.4
Chan, J.R.5
Tangphao, O.6
-
6
-
-
0035936390
-
Risk of acute coronary events and serum concentration of asymmetric dimethylarginine
-
Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, Laaksonen R. Risk of acute coronary events and serum concentration of asymmetric dimethylarginine. Lancet 2001; 358:2127-2128.
-
(2001)
Lancet
, vol.358
, pp. 2127-2128
-
-
Valkonen, V.P.1
Päivä, H.2
Salonen, J.T.3
Lakka, T.A.4
Lehtimäki, T.5
Laakso, J.6
Laaksonen, R.7
-
7
-
-
33750288515
-
Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography
-
Sahinarslan A, Cengel A, Biberoglu G, Hasanoglu A, Turkoglu S, Timurkaynak T. Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography. Coron Artery Dis 2006; 17:605-609.
-
(2006)
Coron Artery Dis
, vol.17
, pp. 605-609
-
-
Sahinarslan, A.1
Cengel, A.2
Biberoglu, G.3
Hasanoglu, A.4
Turkoglu, S.5
Timurkaynak, T.6
-
8
-
-
33747397670
-
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination Investigating the Influence of ADMA Concentration (CARDIAC) study
-
Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination Investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 2006; 152:493.
-
(2006)
Am Heart J
, vol.152
, pp. 493
-
-
Schulze, F.1
Lenzen, H.2
Hanefeld, C.3
Bartling, A.4
Osterziel, K.J.5
Goudeva, L.6
-
9
-
-
27744511357
-
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: Results from the Athero Gene Study
-
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the Athero Gene Study. Circ Res 2005; 97:53-59.
-
(2005)
Circ Res
, vol.97
, pp. 53-59
-
-
Schnabel, R.1
Blankenberg, S.2
Lubos, E.3
Lackner, K.J.4
Rupprecht, H.J.5
Espinola-Klein, C.6
-
10
-
-
33847352106
-
Asymmetric dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study)
-
Meinitzer A, Seelhorst U, Wellnitz B, Halwachs-Baumann G, Boehm BO, Winkelmann BR, März W. Asymmetric dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 2007; 53:273-283.
-
(2007)
Clin Chem
, vol.53
, pp. 273-283
-
-
Meinitzer, A.1
Seelhorst, U.2
Wellnitz, B.3
Halwachs-Baumann, G.4
Boehm, B.O.5
Winkelmann, B.R.6
März, W.7
-
11
-
-
33750724483
-
Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium
-
Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, Simons M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol 1996; 271:713-720.
-
(1996)
Am J Physiol
, vol.271
, pp. 713-720
-
-
Sellke, F.W.1
Wang, S.Y.2
Stamler, A.3
Lopez, J.J.4
Li, J.5
Simons, M.6
-
12
-
-
33750867403
-
Effects of coronary artery disease on expression and microvascular response to VEGF
-
Metais C, Li J, Simons M, Sellke FW. Effects of coronary artery disease on expression and microvascular response to VEGF. Am J Physiol 1998; 275: 1411-1418.
-
(1998)
Am J Physiol
, vol.275
, pp. 1411-1418
-
-
Metais, C.1
Li, J.2
Simons, M.3
Sellke, F.W.4
-
13
-
-
0034687598
-
Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide
-
Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102:3098-3103.
-
(2000)
Circulation
, vol.102
, pp. 3098-3103
-
-
Matsunaga, T.1
Warltier, D.C.2
Weihrauch, D.W.3
Moniz, M.4
Tessmer, J.5
Chilian, W.M.6
-
14
-
-
0034716975
-
Improved method for simultaneous determination of L-arginine and its mono- and dimethylated metabolites in biological samples by high-performance liquid chromatography
-
Pi J, Kumagi Y, Sun G, Shimojo N. Improved method for simultaneous determination of L-arginine and its mono- and dimethylated metabolites in biological samples by high-performance liquid chromatography. J Chromatogr 2000; 742:199-203.
-
(2000)
J Chromatogr
, vol.742
, pp. 199-203
-
-
Pi, J.1
Kumagi, Y.2
Sun, G.3
Shimojo, N.4
-
15
-
-
0022452791
-
Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: A prospective study
-
Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986; 75:325-334.
-
(1986)
Circulation
, vol.75
, pp. 325-334
-
-
Cohen, M.1
Rentrop, K.P.2
-
16
-
-
0025978583
-
Influence of coronary collateral vessels on myocardial infarct size in humans, results of phase I thrombolysis in myocardial infarction (TIMI) trial
-
Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans, results of phase I thrombolysis in myocardial infarction (TIMI) trial. Circulation 1991; 83:739-746.
-
(1991)
Circulation
, vol.83
, pp. 739-746
-
-
Habib, G.B.1
Heibig, J.2
Forman, S.A.3
Brown, B.G.4
Roberts, R.5
Terrin, M.L.6
Bolli, R.7
-
17
-
-
0035205181
-
Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease
-
Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38:1872-1878.
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 1872-1878
-
-
Pohl, T.1
Seiler, C.2
Billinger, M.3
Herren, E.4
Wustmann, K.5
Mehta, H.6
-
18
-
-
33750041643
-
Humoral and cellular factors responsible for coronary collateral formation
-
Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M. Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol 2006; 98:1194-1197.
-
(2006)
Am J Cardiol
, vol.98
, pp. 1194-1197
-
-
Sherman, J.A.1
Hall, A.2
Malenka, D.J.3
De Muinck, E.D.4
Simons, M.5
-
19
-
-
0032960337
-
Effect of diabetes mellitus on formation of coronary collateral vessels
-
Abaci A, Oǧuzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99:2239-2242.
-
(1999)
Circulation
, vol.99
, pp. 2239-2242
-
-
Abaci, A.1
Oǧuzhan, A.2
Kahraman, S.3
Eryol, N.K.4
Unal, S.5
Arinç, H.6
Ergin, A.7
-
20
-
-
0030853575
-
Hyperchotesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines
-
Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, et al. Hyperchotesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 1997; 96:2667-2674.
-
(1997)
Circulation
, vol.96
, pp. 2667-2674
-
-
Van Belle, E.1
Rivard, A.2
Chen, D.3
Silver, M.4
Bunting, S.5
Ferrara, N.6
-
21
-
-
23044509023
-
Impaired coronary collateral vessel development in patients with metabolic syndrome
-
Turhan H, Yasar AS, Erbay AR, Yetkin E, Sasmaz H, Sabah I. Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis 2005; 16:281-285.
-
(2005)
Coron Artery Dis
, vol.16
, pp. 281-285
-
-
Turhan, H.1
Yasar, A.S.2
Erbay, A.R.3
Yetkin, E.4
Sasmaz, H.5
Sabah, I.6
-
22
-
-
0347511010
-
Obesity is associated with impaired coronary collateral vessel development
-
Yilmaz MB, Biyikoglu SF, Akin Y, Guray U, Kisacik HL, Korkmaz S. Obesity is associated with impaired coronary collateral vessel development. Int J Obes 2003; 27:1541-1545.
-
(2003)
Int J Obes
, vol.27
, pp. 1541-1545
-
-
Yilmaz, M.B.1
Biyikoglu, S.F.2
Akin, Y.3
Guray, U.4
Kisacik, H.L.5
Korkmaz, S.6
-
23
-
-
0037219525
-
Enhancement of ischemia-induced angiogenesis by eNOS overexpression
-
Amano K, Matsubara H, Iba O, Okigaki M, Fujiyama S, Imada T, et al. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Hypertension 2003; 41:156-162.
-
(2003)
Hypertension
, vol.41
, pp. 156-162
-
-
Amano, K.1
Matsubara, H.2
Iba, O.3
Okigaki, M.4
Fujiyama, S.5
Imada, T.6
-
24
-
-
0032102292
-
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
-
Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia J Clin Invest 1998; 101:2567-2578.
-
(1998)
J Clin Invest
, vol.101
, pp. 2567-2578
-
-
Murohara, T.1
Asahara, T.2
Silver, M.3
Bauters, C.4
Masuda, H.5
Kalka, C.6
-
25
-
-
0030444979
-
Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb
-
Unthank JL, Nixon JC, Dalsing MC. Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb. J Vasc Res 1996; 33:471-479.
-
(1996)
J Vasc Res
, vol.33
, pp. 471-479
-
-
Unthank, J.L.1
Nixon, J.C.2
Dalsing, M.C.3
-
26
-
-
43949125497
-
Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development
-
Epub Nov 19
-
Gulec S, Karabulut H, Ozdemir AO, Ozdol C, Turhan S, Altin T, et al. Glu298Asp polymorphism of the eNOS gene is associated with coronary collateral development. Atherosclerosis 2008; 198:354-359. Epub 2007 Nov 19.
-
(2007)
Atherosclerosis 2008
, vol.198
, pp. 354-359
-
-
Gulec, S.1
Karabulut, H.2
Ozdemir, A.O.3
Ozdol, C.4
Turhan, S.5
Altin, T.6
-
27
-
-
20144362691
-
Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis
-
Jacobi J, Sydow K, von Degenfeld G, Zhang Y, Dayoub H, Wang B, et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation 2005; 111:1431-1438.
-
(2005)
Circulation
, vol.111
, pp. 1431-1438
-
-
Jacobi, J.1
Sydow, K.2
von Degenfeld, G.3
Zhang, Y.4
Dayoub, H.5
Wang, B.6
-
28
-
-
4444248826
-
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: Involvement of renin-angiotensin system and oxidative stress
-
Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S, et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol 2004; 24:1682-1688.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1682-1688
-
-
Suda, O.1
Tsutsui, M.2
Morishita, T.3
Tasaki, H.4
Ueno, S.5
Nakata, S.6
|